Natco Pharma stock corrected sharply due to weak Q3 results, but future opportunities like semaglutide offer hope.

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

Ozempic/Wegovy is the first drug on HHS's 2025 ... as the biggest flaw in the IRA - the shorter window time for small molecule drugs vs biologics, dubbed the "pill penalty" by the industry.

Beauty and Cosmetic Surgery Guide, Anna Pasternak reveals why society’s most refined faces are signing up for a more mindful ...

DUBAI: Dubai’s Arab Health medical expo could be the medicine to the Pakistani pharmaceutical and surgical industry’s market ...

Mounjaro is a single-molecule treatment that can be self-injected ... numbers to hide behind when it’s one-on-one. Mounjaro v. Ozempic The FDA approval for Mounjaro was based on a series of ...

Eli Lilly and Company’s LLY shares have risen 4.3% since it reported fourth-quarter results on Feb. 6. Lilly’s fourth-quarter ...

Along with researchers in the Faculty of Health Sciences and the Faculty of Science, Western projects received a total of $17 ...

Rapid fat loss from GLP-1 medications like Ozempic can lead to 'Ozempic face', characterized by hollow cheeks and sagging skin. Drinking water, eating a protein-rich diet, and practicing face yoga ...

Experts have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind. Several studies have linked the shots to conditions that cause inflammation and block blood ...

Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment. Never before was there a drug that actually worked for weight loss.